| Previous Close | 4.9700 |
| Open | 4.9800 |
| Bid | 4.9900 x 0 |
| Ask | 5.0000 x 0 |
| Day's Range | 4.9800 - 5.0000 |
| 52 Week Range | 2.3500 - 5.0800 |
| Volume | 36,834 |
| Avg. Volume | 217,911 |
| Market Cap | 357.386M |
| Beta (5Y Monthly) | 3.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4160 |
| Earnings Date | Mar. 16, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Apr. 29, 1998 |
| 1y Target Est | 3.67 |
- Simply Wall St.
If You Had Bought CRH Medical (TSE:CRH) Stock A Year Ago, You Could Pocket A 78% Gain Today
The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you...
- CNW Group
WELL Health Provides an Update on its Proposed Acquisition of CRH Medical
WELL Health Technologies Corp. (TSX: WELL) ("WELL" or the "Company"), a company focused on consolidating and modernizing clinical and digital assets within the healthcare sector, is pleased to announce that on April 16, 2021, the securityholders of CRH Medical Corporation ("CRH") (TSX: CRH) (NYSE: CRHM) approved the acquisition of CRH by a subsidiary of WELL for US$4.00 per share in cash (the "Acquisition"). As previously announced on February 8, 2021, this Acquisition represents an equity consideration of approximately US$292.7 million and a transaction value of approximately US$369.2 million, inclusive of CRH's credit facility. The Acquisition is subject to court and regulatory approvals and clearances, as well as other customary closing conditions. Subject to the satisfaction of such conditions, the Acquisition is expected to be completed on or about April 22, 2021.
- CNW Group
CRH Medical Securityholders Approve Acquisition by WELL Health
CRH Medical Corporation (TSX: CRH) (NYSE: CRHM) ("CRH" or the "Company") today announced that its securityholders approved the acquisition of CRH by a subsidiary of WELL Health Technologies Corp. ("WELL Health") at the special meeting of CRH securityholders today.
